関連する実験動画
Updated: Jul 14, 2026

15:48
ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
Published on: July 29, 2007
アミオトロフィック横筋硬化症 (ALS)
1Motor Neurone Disease Care and Research Centre, Royal Preston Hospital, Fulwood, Preston PR2 9HT, UK.
Lancet (London, England)
|June 19, 2007
まとめ
アミオトロフィック横筋硬化症 (ALS),またはモーターニューロン疾患は,複雑な神経学的疾患です. このレビューは,ALSの自然史,原因,治療法,症状管理,および幹細胞療法などの将来の研究方向性に関するものです.
科学分野:
- 神経学 神経学とは
- 神経科学は神経科学である.
背景:
- アミオトロフィック横筋硬化症 (ALS) は,モーターニューロン疾患としても知られており,その病原性を理解する上で複雑な課題を提示しています.
- この状態は,世界中で個人に影響を及ぼし,その多面的な側面の包括的なレビューを必要とします.
研究 の 目的:
- アミオトロフィック横筋硬化症 (ALS) の包括的な概要を提供するために.
- ALSの自然史,臨床的特徴,診断,遺伝学,流行病学に関する現在の知識について議論する.
- ALSの潜在的な原因,治療法,症状管理,および将来の研究方法を探求する.
主な方法:
- アミオトロフィック横筋硬化症 (ALS) の文献レビュー.
- ALSの自然史,臨床表現,診断基準,流行病学に関する情報の統合.
- エチオロジカルな仮説,治療戦略,疾患管理に関する議論.
主要な成果:
- ALSは不確実な病原性によって特徴づけられ,興奮毒性および酸化ストレスを含む仮説があります.
- マネジメント戦略には,症状のコントロール (消化不全,不発症,呼吸障害,痛み,心理的障害) と緩和ケアが含まれます.
- 将来の見通しには,疾患マーカー,幹細胞,およびALSに対する遺伝子治療が含まれています.
結論:
- ALSの効果的な管理には,患者と家族の身体的,心理的,精神的なニーズに対応する必要があります.
- 疾患マーカーや幹細胞や遺伝子治療のような新しい治療法に関する継続的な研究は,ALSの治療に期待を寄せている.
- 多分野的なアプローチは,アミオトロフィック横筋硬化症 (ALS) の治療と治療結果を最適化するために不可欠です.
関連する概念動画
Cross-bridge Cycle
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Alterations in Muscle Tone ll
Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
Satellite Stem Cells and Muscular Dystrophy
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

